Connor W Hoban, Chao Zhang, Yuxuan Jin, Paul M Saluan, Lutul D Farrow, James T Rosneck, Morgan H Jones, Anthony Miniaci, Brian M Leo, Richard D Parker, Michael W Kattan, Kurt P Spindler
{"title":"The Effect of a Hamstring Tendon Autograft With a Diameter ≥8 mm on Graft Failure or Contralateral ACL Ruptures at 2 Years After ACL Reconstruction.","authors":"Connor W Hoban, Chao Zhang, Yuxuan Jin, Paul M Saluan, Lutul D Farrow, James T Rosneck, Morgan H Jones, Anthony Miniaci, Brian M Leo, Richard D Parker, Michael W Kattan, Kurt P Spindler","doi":"10.1177/23259671251321831","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A decreased hamstring tendon (HT) autograft diameter has been associated with higher rates of failure in primary anterior cruciate ligament reconstruction (ACLR).</p><p><strong>Purpose: </strong>To determine whether an HT autograft diameter ≥8 mm has an effect on the risk of graft failure and subsequent knee surgery after ACLR in a prospective cohort.</p><p><strong>Study design: </strong>Cohort study; Level of evidence, 2.</p><p><strong>Methods: </strong>Patients undergoing primary ACLR with an HT autograft were included and followed prospectively for 2 years to capture subsequent surgery events performed in either knee. The effect of HT autograft diameter on the risk of subsequent surgery was analyzed using multivariable regression modeling that adjusted for patient age, sex, body mass index, and Marx activity score.</p><p><strong>Results: </strong>Of 421 eligible patients, 381 (90.5%) had a minimum 2-year follow-up and were included in analysis. The median autograft diameter was 8.5 mm (interquartile range, 8.0-9.0 mm); 90.8% of patients received an autograft with a diameter ≥8 mm. There were 59 patients (15.5%) who underwent subsequent ipsilateral knee surgery, including 27 patients (7.1%) who had graft failure and underwent revision ACLR within 2 years. HT autograft diameter was not associated with the risk of all subsequent ipsilateral knee surgery (odds ratio [OR], 0.87 [95% CI, 0.56-1.36]; <i>P</i> = .536) or revision ACLR (OR, 0.71 [95% CI, 0.38-1.33]; <i>P</i> = .286). A Marx activity score ≥12 was associated with an increased risk of all subsequent ipsilateral knee surgery (OR, 2.55 [95% CI, 1.41-4.59]; <i>P</i> = .002). Younger age was associated with an increased risk of revision ACLR (OR, 0.16 [95% CI, 0.05-0.51]; <i>P</i> = .002).</p><p><strong>Conclusion: </strong>A minimum HT autograft diameter of 8 mm was not associated with the risk of revision ACLR or other subsequent surgery in the ipsilateral or contralateral knee. This study may guide intraoperative decision making regarding HT autograft implementation in ACLR.</p>","PeriodicalId":19646,"journal":{"name":"Orthopaedic Journal of Sports Medicine","volume":"13 8","pages":"23259671251321831"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344349/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orthopaedic Journal of Sports Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/23259671251321831","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: A decreased hamstring tendon (HT) autograft diameter has been associated with higher rates of failure in primary anterior cruciate ligament reconstruction (ACLR).
Purpose: To determine whether an HT autograft diameter ≥8 mm has an effect on the risk of graft failure and subsequent knee surgery after ACLR in a prospective cohort.
Study design: Cohort study; Level of evidence, 2.
Methods: Patients undergoing primary ACLR with an HT autograft were included and followed prospectively for 2 years to capture subsequent surgery events performed in either knee. The effect of HT autograft diameter on the risk of subsequent surgery was analyzed using multivariable regression modeling that adjusted for patient age, sex, body mass index, and Marx activity score.
Results: Of 421 eligible patients, 381 (90.5%) had a minimum 2-year follow-up and were included in analysis. The median autograft diameter was 8.5 mm (interquartile range, 8.0-9.0 mm); 90.8% of patients received an autograft with a diameter ≥8 mm. There were 59 patients (15.5%) who underwent subsequent ipsilateral knee surgery, including 27 patients (7.1%) who had graft failure and underwent revision ACLR within 2 years. HT autograft diameter was not associated with the risk of all subsequent ipsilateral knee surgery (odds ratio [OR], 0.87 [95% CI, 0.56-1.36]; P = .536) or revision ACLR (OR, 0.71 [95% CI, 0.38-1.33]; P = .286). A Marx activity score ≥12 was associated with an increased risk of all subsequent ipsilateral knee surgery (OR, 2.55 [95% CI, 1.41-4.59]; P = .002). Younger age was associated with an increased risk of revision ACLR (OR, 0.16 [95% CI, 0.05-0.51]; P = .002).
Conclusion: A minimum HT autograft diameter of 8 mm was not associated with the risk of revision ACLR or other subsequent surgery in the ipsilateral or contralateral knee. This study may guide intraoperative decision making regarding HT autograft implementation in ACLR.
期刊介绍:
The Orthopaedic Journal of Sports Medicine (OJSM), developed by the American Orthopaedic Society for Sports Medicine (AOSSM), is a global, peer-reviewed, open access journal that combines the interests of researchers and clinical practitioners across orthopaedic sports medicine, arthroscopy, and knee arthroplasty.
Topics include original research in the areas of:
-Orthopaedic Sports Medicine, including surgical and nonsurgical treatment of orthopaedic sports injuries
-Arthroscopic Surgery (Shoulder/Elbow/Wrist/Hip/Knee/Ankle/Foot)
-Relevant translational research
-Sports traumatology/epidemiology
-Knee and shoulder arthroplasty
The OJSM also publishes relevant systematic reviews and meta-analyses.
This journal is a member of the Committee on Publication Ethics (COPE).